JP2007528388A5 - - Google Patents

Download PDF

Info

Publication number
JP2007528388A5
JP2007528388A5 JP2007502436A JP2007502436A JP2007528388A5 JP 2007528388 A5 JP2007528388 A5 JP 2007528388A5 JP 2007502436 A JP2007502436 A JP 2007502436A JP 2007502436 A JP2007502436 A JP 2007502436A JP 2007528388 A5 JP2007528388 A5 JP 2007528388A5
Authority
JP
Japan
Prior art keywords
mixtures
composition
fatty acid
solid
phthalate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007502436A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007528388A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2005/000665 external-priority patent/WO2005087194A1/en
Publication of JP2007528388A publication Critical patent/JP2007528388A/ja
Publication of JP2007528388A5 publication Critical patent/JP2007528388A5/ja
Pending legal-status Critical Current

Links

JP2007502436A 2004-03-10 2005-03-10 分子分散されたドロスピレノンを含む組成物 Pending JP2007528388A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55135504P 2004-03-10 2004-03-10
EP04075713 2004-03-10
PCT/IB2005/000665 WO2005087194A1 (en) 2004-03-10 2005-03-10 Compositions comprising drospirenone molecularly dispersed

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010068645A Division JP2010150289A (ja) 2004-03-10 2010-03-24 分子分散されたドロスピレノンを含む組成物

Publications (2)

Publication Number Publication Date
JP2007528388A JP2007528388A (ja) 2007-10-11
JP2007528388A5 true JP2007528388A5 (cg-RX-API-DMAC7.html) 2008-04-24

Family

ID=34961545

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007502436A Pending JP2007528388A (ja) 2004-03-10 2005-03-10 分子分散されたドロスピレノンを含む組成物
JP2010068645A Pending JP2010150289A (ja) 2004-03-10 2010-03-24 分子分散されたドロスピレノンを含む組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010068645A Pending JP2010150289A (ja) 2004-03-10 2010-03-24 分子分散されたドロスピレノンを含む組成物

Country Status (22)

Country Link
EP (2) EP1980242B1 (cg-RX-API-DMAC7.html)
JP (2) JP2007528388A (cg-RX-API-DMAC7.html)
KR (1) KR20060130723A (cg-RX-API-DMAC7.html)
AT (2) ATE429900T1 (cg-RX-API-DMAC7.html)
AU (2) AU2005221402B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0508612A (cg-RX-API-DMAC7.html)
CA (1) CA2558393A1 (cg-RX-API-DMAC7.html)
CR (1) CR8631A (cg-RX-API-DMAC7.html)
CU (1) CU20060173A7 (cg-RX-API-DMAC7.html)
CY (1) CY1109265T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005014227D1 (cg-RX-API-DMAC7.html)
DK (1) DK1748756T3 (cg-RX-API-DMAC7.html)
EA (1) EA012570B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP066901A (cg-RX-API-DMAC7.html)
ES (1) ES2325591T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20090381T1 (cg-RX-API-DMAC7.html)
IL (1) IL177893A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ549792A (cg-RX-API-DMAC7.html)
PL (1) PL1748756T3 (cg-RX-API-DMAC7.html)
PT (1) PT1748756E (cg-RX-API-DMAC7.html)
SI (1) SI1748756T1 (cg-RX-API-DMAC7.html)
WO (1) WO2005087194A1 (cg-RX-API-DMAC7.html)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY142989A (en) 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
US8475838B2 (en) 2005-06-03 2013-07-02 Sandoz Ag Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
EP1767194A1 (de) * 2005-06-09 2007-03-28 Helm AG Verfahren zur Herstellung von Adsorbaten des Drospirenons
CA2626579A1 (en) * 2005-10-25 2007-05-03 Abbott Laboratories Formulation comprising a drug of low water solubility and method of use thereof
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone
RU2678833C2 (ru) * 2008-09-17 2019-02-04 Киазма Инк. Фармацевтические композиции и соответствующие способы доставки
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
CA2752805A1 (en) * 2009-02-18 2010-08-26 Bayer Pharma Aktiengesellschaft Formulation comprising drospirenone for subcutaneous or intramuscular administration
KR20150043548A (ko) 2009-10-01 2015-04-22 앱탈리스 파마테크, 인코포레이티드 경구 투여용 코르티코스테로이드 조성물
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
EP3459533A1 (en) 2010-08-04 2019-03-27 Grünenthal GmbH Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN103040725B (zh) * 2012-12-26 2015-01-21 武汉九珑人福药业有限责任公司 一种利用研磨改善屈螺酮溶出的方法及屈螺酮固体分散体
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
MY176771A (en) 2013-06-25 2020-08-21 Olam International Ltd Processes for producing dark brown natural cocoa
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
KR20170040209A (ko) 2014-07-29 2017-04-12 쎄러퓨틱스엠디, 인코퍼레이티드 경피 크림
SI3253401T1 (sl) 2015-02-03 2025-07-31 Amryt Endo, Inc. Zdravljenje akromegalije z oralnim oktreotidom
MX2017011469A (es) * 2015-03-10 2018-01-23 Shionogi Inc Dispersiones sólidas.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
US12691128B2 (en) 2019-10-01 2026-07-28 Ellodi Pharmaceuticals, L.P. Methods of treating eosinophilic esophagitis and reducing candidiasis
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5770815A (en) * 1980-10-21 1982-05-01 Furointo Sangyo Kk Absorption improver
JPS5942313A (ja) * 1982-09-01 1984-03-08 Teijin Ltd ポリビニルポリピロリドンを用いた製剤
JPH0723303B2 (ja) * 1986-03-07 1995-03-15 株式会社資生堂 難溶性薬物含有マイクロエマルシヨン製剤
DE3702029A1 (de) * 1987-01-24 1988-08-04 Basf Ag Waessriges oder pulverfoermiges, wasserdispergierbares praeparat eines in wasser schwerloeslichen pharmazeutischen wirkstoffs und verfahren zu seiner herstellung
DE3916112A1 (de) * 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
DE4326240A1 (de) * 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols
EP0952770A4 (en) * 1995-09-07 1999-12-22 Fuisz Technologies Ltd SYSTEM FOR MAKING SUBSTANTIALLY NON-SOLUBLE BIOALTERANT AGENTS BIOAVAILABLE
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
AU3843999A (en) * 1998-05-07 1999-11-23 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
DK1380301T3 (da) * 1999-08-31 2009-04-20 Bayer Schering Pharma Ag Farmaceutisk sammensætning af ethinylestradiol og drospirenon til anvendelse som svangerskabsforebyggende middel
AU2001225413B2 (en) * 2000-01-18 2005-06-23 Bayer Schering Pharma Aktiengesellschaft Drospirenone for hormone replacement therapy
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
EP1260225A1 (en) * 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
CN101785775B (zh) * 2002-09-05 2015-03-25 潘塔希生物科学股份有限公司 15-或16-位取代的睾酮类似物的药物学应用
WO2004041289A1 (en) * 2002-11-05 2004-05-21 Schering Aktiengesellschaft Cardiovascular protection using anti-aldosteronic progestins

Similar Documents

Publication Publication Date Title
TWI382840B (zh) C型肝炎病毒(hcv)前藥調配物
JP2007528901A5 (cg-RX-API-DMAC7.html)
JP2007523872A5 (cg-RX-API-DMAC7.html)
JP2012097088A (ja) 医薬製剤
JP2005320354A5 (cg-RX-API-DMAC7.html)
JP2011503048A5 (cg-RX-API-DMAC7.html)
KR20140142173A (ko) 가열 용융 압출용 조성물 및 이를 이용한 가열 용융 압출 성형물의 제조 방법
JP2021535199A5 (cg-RX-API-DMAC7.html)
CN103269691A (zh) 用于控制释放美沙拉嗪的口服药物片剂和其获得方法
KR20090130325A (ko) 약학 부형제 복합체
JP2013525394A (ja) 経口投与剤形
CN101330904B (zh) 含有低熔点活性成分的固体分散体以及含有它的口服给药片剂
JP2011502140A5 (cg-RX-API-DMAC7.html)
KR100522239B1 (ko) 아세트아미노펜을 함유하는 제어방출성의 경구용 제제
CN101631533A (zh) 含有西洛他唑的控释制剂及其制备方法
KR20170009897A (ko) 알리사르탄 이소프록실 고체 분산체 및 이의 약제학적 조성물
US20070116757A1 (en) Methylene Blue Derivatives
JP2022177014A (ja) Hcvを処置するための固体医薬組成物
Xia et al. Approaches to developing fast release pellets via wet extrusion-spheronization
EP2359814A1 (en) Pharmaceutical mini-tablets for sustained release of flecainide acetate
RU2017102990A (ru) Твёрдая дисперсия аллисартана изопроксила и фармацевтическая композиция
KR20230109980A (ko) 엔잘루타마이드 고체분산체
RU2020109948A (ru) Экструдированные композиции энзалутамида
JP2009502968A5 (cg-RX-API-DMAC7.html)
CN101703488A (zh) 具有润滑层结构的双层渗透泵控释片及其制备方法